Charles River Laboratories ROA 2006-2018 | CRL

Current and historical return on assets (ROA) values for Charles River Laboratories (CRL) over the last 10 years. Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets. Charles River Laboratories ROA for the three months ending September 30, 2018 was 8.54%.
Charles River Laboratories ROA - Return on Assets Historical Data
Date TTM Net Income Total Assets Return on Assets
2018-09-30 $0.14B $3.80B 4.03%
2018-06-30 $0.13B $3.87B 4.07%
2018-03-31 $0.13B $3.00B 4.46%
2017-12-31 $0.12B $2.93B 4.37%
2017-09-30 $0.20B $2.87B 7.17%
2017-06-30 $0.18B $2.77B 6.77%
2017-03-31 $0.17B $2.70B 6.08%
2016-12-31 $0.16B $2.71B 6.04%
2016-09-30 $0.14B $2.69B 5.90%
2016-06-30 $0.14B $2.76B 6.29%
2016-03-31 $0.16B $2.10B 7.66%
2015-12-31 $0.15B $2.07B 7.66%
2015-09-30 $0.15B $2.03B 7.59%
2015-06-30 $0.14B $1.89B 7.52%
2015-03-31 $0.13B $1.85B 6.79%
2014-12-31 $0.13B $1.87B 6.97%
2014-09-30 $0.12B $1.84B 6.75%
2014-06-30 $0.12B $1.86B 6.89%
2014-03-31 $0.11B $1.65B 6.66%
2013-12-31 $0.10B $1.63B 6.34%
2013-09-30 $0.10B $1.64B 6.32%
2013-06-30 $0.09B $1.62B 5.83%
2013-03-31 $0.10B $1.60B 6.09%
2012-12-31 $0.10B $1.59B 6.14%
2012-09-30 $0.11B $1.57B 6.74%
2012-06-30 $0.10B $1.55B 6.53%
2012-03-31 $0.10B $1.56B 6.50%
2011-12-31 $0.11B $1.56B 6.61%
2011-09-30 $-0.26B $1.59B -15.48%
2011-06-30 $-0.31B $1.71B -16.85%
2011-03-31 $-0.32B $1.75B -16.80%
2010-12-31 $-0.34B $1.73B -16.57%
2010-09-30 $0.02B $2.08B 1.11%
2010-06-30 $0.09B $2.16B 3.94%
2010-03-31 $0.11B $2.19B 4.85%
2009-12-31 $0.11B $2.20B 5.28%
2009-09-30 $-0.57B $2.19B -26.45%
2009-06-30 $-0.56B $2.15B -24.09%
2009-03-31 $-0.54B $2.09B -21.72%
2008-12-31 $-0.53B $2.14B -19.49%
2008-09-30 $0.17B $2.90B 5.98%
2008-06-30 $0.17B $2.89B 5.99%
2008-03-31 $0.16B $2.85B 5.72%
2007-12-31 $0.15B $2.81B 5.61%
2007-09-30 $0.15B $2.74B 5.81%
2007-06-30 $0.09B $2.66B 3.61%
2007-03-31 $0.08B $2.57B 3.16%
2006-12-31 $-0.06B $2.56B -2.22%
2006-09-30 $-0.04B $2.50B -1.63%
2006-06-30 $0.01B $2.62B 0.32%
2006-03-31 $0.01B $2.41B 0.56%
2005-12-31 $0.14B $2.54B 5.51%
Sector Industry Market Cap Revenue
Medical Medical Services $6.012B $1.858B
Charles River Laboratories International, Inc. provides essential products and services to help pharmaceutical and biotechnology companies, government agencies and leading academic institutions around the globe accelerate their research and drug development efforts. Their dedicated employees are focused on providing clients with exactly what they need to improve and expedite the discovery, early-stage development and safe manufacture of new therapies for the patients who need them. At Charles River, they are passionate about their role in improving the quality of people's lives. Their mission, their excellent science and strong sense of purpose guide in all that they do, and they approach each day with the knowledge that their work helps to improve the health and well-being of many across the globe. Charles River Laboratories International, Inc. service areas are Basic research, discovery, safety and efficacy, clinical support and manufacturing.
Stock Name Country Market Cap PE Ratio
Express Scripts Holding (ESRX) United States $54.638B 11.29
ICON (ICLR) Ireland $6.920B 21.69
PRA Health Sciences (PRAH) United States $6.277B 25.63
Premier (PINC) United States $5.275B 17.90
INC Research Holdings (SYNH) United States $4.800B 19.38
HealthEquity (HQY) United States $4.740B 99.21
Teladoc (TDOC) United States $3.711B 0.00
AMN Healthcare Services Inc (AMN) United States $2.883B 19.78
NovoCure (NVCR) Jersey $2.674B 0.00
BioTelemetry (BEAT) United States $2.016B 35.61
Medpace Holdings (MEDP) United States $1.851B 22.91
Healthways (TVTY) United States $1.480B 18.20
Intrexon (XON) United States $1.304B 0.00
IKang Healthcare (KANG) China $1.169B 58.03
CareDx (CDNA) United States $1.020B 0.00
Natera (NTRA) United States $0.957B 0.00
China Cord Blood (CO) China $0.802B 21.29
Apollo Medical Holdings (AMEH) United States $0.635B 0.00
Surgery Partners (SGRY) United States $0.618B 0.00
Establishment Labs Holdings (ESTA) $0.521B 0.00
Civitas Solutions (CIVI) United States $0.516B 10.18
OncoCyte (OCX) United States $0.069B 0.00
Interpace Diagnostics (IDXG) United States $0.032B 0.00
Cancer Genetics (CGIX) United States $0.013B 0.00
OpGen (OPGN) United States $0.007B 0.00
FORM Holdings (XSPA) United States $0.005B 0.00
Biocept (BIOC) United States $0.004B 0.00